Atlas Trials

A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue

Clinical trial NCT07248020 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07248020
Sponsor
Chang Gung Memorial Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal CancerLocally Advanced Rectal CancerRadiation-Induced EnteritisRadiation ProctitisChemoradiotherapy-Related Toxicity
Start date
2026-01-01
Primary completion
2028-12-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.